Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
- PMID: 17451840
- DOI: 10.1016/j.addr.2007.03.004
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Abstract
The cellular membrane constitutes an effective barrier that offers protection for the complex, yet highly ordered, intracellular environment that defines the cell. Passage of molecules across this barrier is highly regulated and highly restricted, with molecular size being the most significant criteria. Over the last 15 years, a class of small cationic peptides has been discovered that can defy the rules of membrane passage and can gain access to the intracellular environment. Importantly, cellular entrance is also permitted for covalently coupled cargo. The cationic nature of these peptides is crucial for their ability to bind and traverse the anionic cellular membrane. Cell penetrating peptides (CPPs) have been used for the delivery of a wide range of macromolecules including peptides, proteins and antisense oligonucleotides. With the recent advancement and understanding of RNA interference (RNAi), CPPs offer an attractive means for the cellular uptake of double-stranded siRNAs to induce a RNAi response. This review focuses on the potential use of CPPs to deliver siRNA into cells and the implications of this technology for both gene function determination and therapeutic potential.
Similar articles
-
Peptide vectors for the nonviral delivery of nucleic acids.Acc Chem Res. 2012 Jul 17;45(7):1048-56. doi: 10.1021/ar2002304. Epub 2012 Mar 28. Acc Chem Res. 2012. PMID: 22455499
-
Recent advances in the use of cell-penetrating peptides for medical and biological applications.Adv Drug Deliv Rev. 2009 Sep 30;61(11):953-64. doi: 10.1016/j.addr.2009.06.001. Epub 2009 Jun 16. Adv Drug Deliv Rev. 2009. PMID: 19538995 Review.
-
siRNA delivery using peptide transduction domains.Trends Pharmacol Sci. 2009 Jul;30(7):341-5. doi: 10.1016/j.tips.2009.04.009. Epub 2009 Jun 21. Trends Pharmacol Sci. 2009. PMID: 19545914 Review.
-
Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.IUBMB Life. 2010 Mar;62(3):183-93. doi: 10.1002/iub.297. IUBMB Life. 2010. PMID: 20101631 Review.
-
Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.Nanomedicine. 2009 Mar;5(1):8-20. doi: 10.1016/j.nano.2008.06.001. Epub 2008 Jul 18. Nanomedicine. 2009. PMID: 18640078 Review.
Cited by
-
Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications.Bioconjug Chem. 2019 Feb 20;30(2):366-383. doi: 10.1021/acs.bioconjchem.8b00761. Epub 2019 Jan 29. Bioconjug Chem. 2019. PMID: 30608140 Free PMC article. Review.
-
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.Mol Ther. 2014 Jan;22(1):69-80. doi: 10.1038/mt.2013.214. Epub 2013 Sep 12. Mol Ther. 2014. PMID: 24025751 Free PMC article.
-
Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells.J Biol Chem. 2008 Apr 25;283(17):11752-62. doi: 10.1074/jbc.M708849200. Epub 2008 Feb 21. J Biol Chem. 2008. PMID: 18292083 Free PMC article.
-
Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides.Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):530-6. doi: 10.1016/j.addr.2007.10.004. Epub 2007 Oct 22. Adv Drug Deliv Rev. 2008. PMID: 18155315 Free PMC article. Review.
-
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.Nucleic Acids Res. 2012 Jul;40(13):6319-37. doi: 10.1093/nar/gks294. Epub 2012 Mar 30. Nucleic Acids Res. 2012. PMID: 22467215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources